Project Grant HT9425261E292
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- The Defense Health Agency (DHA) awarded the University of Washington a $543,285 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2028. This award supports research focused on transforming rhabdomyosarcoma treatment through the development and evaluation of new FDA-approved combination therapies. The project will be conducted at the University of Washington's Seattle, Washington location under the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco (UCSF) a $1,999,190 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2026, through September 29, 2030. This award supports UCSF's participation as a clinical research site within the Prostate Cancer Clinical Trials Consortium, a multi-institutional initiative focused on advancing prostate cancer research...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1,992,959 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2026. The award funds the establishment and operation of the PCRP (Prostate Cancer Research Program) Clinical Consortium as a clinical research site located in Durham, North Carolina, with a performance period extending through September...
- This Project Grant award of $1,412,000 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a biorepository and community development project to characterize aggressive urothelial cancer variants. The University of Washington, as the prime awardee, will conduct this research over a period of approximately 4 years, from September 2024 through August 2028. The project aims to expand understanding of aggressive forms of urothelial (bladder)...
- The University of Washington received a $1.49 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded April 1, 2026, with a completion date of March 31, 2029. The project focuses on developing biomaterial strategies to improve the specificity and efficacy of chimeric antigen receptor (CAR) T cell therapy for breast cancer treatment. This three-year research initiative will be conducted at the University of...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $525,847 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 15, 2025 through July 14, 2027. The award supports research to define and exploit essential components of the androgen receptor program operative in castration-resistant prostate cancers. This research addresses a critical health challenge affecting military...
- Federal Grant Award Summary The University of Washington's Office of Sponsored Programs received a $498,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, through July 31, 2028. The grant supports research investigating anti-dystrophin T cell responses in patients with Duchenne muscular dystrophy (DMD), a progressive genetic muscle disorder affecting the military-relevant population....
- Federal Grant Award Summary The University of Washington Office of Sponsored Programs received a $1.40 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The award supports research titled "Dynamics of ecdNA Chromatin Topology and Molecular Structures Shaping Glioma Treatment Response," to be conducted at the University of Washington in...
- The Defense Health Agency awarded a $1,036,233 Project Grant to the Fred Hutchinson Cancer Research Center under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 through June 2024 to develop more precise molecular classification and targeted treatment of metastatic castration-resistant prostate cancer (MCRPC) through multi-omic analysis of circulating tumor DNA (ctDNA). By leveraging ctDNA analysis, the research aims to transform...
- The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...